Presentation

A 22% granulate formulation of Fenbendazole as a ready to administer oral anthelmintic for horses. 1 g Panacur Equine Granules contains 0.22 g active ingredient Fenbendazole, PhEur. 

Uses

A broad-spectrum anthelmintic for the treatment and control of adult and immature roundworms of the gastro-intestinal tract in horses and other equines. Panacur also has an ovicidal effect on nematode eggs. 

Horses:

Panacur effectively treats and controls the following roundworm infections.

Large strongyles (adults and migrating larval stages of S. vulgaris; adults and tissue larval stages of S. edentatus).

Adult and immature small strongyles (Cyathostomes) (benzimidazole susceptible) including encysted mucosal 3rd and 4th stage larvae; it is also effective against inhibited 3rd stage larvae (encysted) in the mucosa.

Adult and immature Oxyuris spp., Strongyloides spp. and Parascaris equorum.

Dosage and administration

Horses: For routine treatment of horses administer orally 5 g Panacur Equine Granules per 150 kg bodyweight.

(= 7.5 mg fenbendazole/kg bodyweight)

Practical dosage recommendations:

  Up to 150 kg                          5 g

  151 to 300 kg                         10 g

  301 to 450 kg                         15 g

  451 to 600 kg                         20 g

  601 to 750 kg                         25 g

  751 to 900 kg                         30 g

Panacur Equine Granules sachet packs each contain 10.2 g of granules and can be used as follows:

Increased dosing for specific infections
Five day course

For the treatment and control of migrating larval and tissue stages of large strongyles, encysted mucosal 3rd and 4th stage larvae and inhibited 3rd stage larvae (encysted) in the mucosa, administer 5g Panacur Equine Granules per 150kg bodyweight daily for 5 days.

(=7.5mg fenbendazole/kg bodyweight daily for 5 days)

Single dose treatments

For the treatment and control of encysted mucosal stages of small strongyles, administer 20g Panacur Equine Granules per 150kg bodyweight (=30mg fenbendazole /kg bodyweight).

For the treatment and control of migrating larval and tissue stages of large strongyles, administer 40g Panacur Equine Granules per 150 kg bodyweight (=60mg fenbendazole /kg bodyweight).

Diarrhoea caused by Strongyloides westeri in two to three week old suckling foals should be treated with Panacur 10% suspension at a dose rate of 25ml per 50kg bodyweight (=50mg fenbendazole /kg bodyweight).

Panacur Equine Granules should be sprinkled onto concentrate or grain feed and the full dosage given as one administration.

Assess bodyweight as accurately as possible before calculating the dosage. The use of a `weigh band' is recommended.

Pregnant mares and young foals may be safely treated with fenbendazole at therapeutic dosage levels.

Recommended dosing programme

All horses should be routinely wormed with the single dose of Panacur Equine Granules every 6-8 weeks.

Treatment of encysted mucosal dwelling larvae should ideally be done in the autumn (late October/November) and again in the Spring. However, for horses that fail to maintain condition or bought-in horses with unknown worming history, the treatment can be given at any time of the year.

Contra-indications, warnings, etc

Do not use in horses intended for human consumption.

Operator warnings

Direct contact with the skin should be kept to a minimum. Wash hands after use.

Environmental warnings

Dispose of any unused product and empty sachets in accordance with guidance from your local waste regulation authority.

For animal treatment only. Keep out of reach of children.

Assess bodyweight as accurately as possible before calculating the dosage.

Pharmaceutical precautions

None.

Legal category

PML

Package quantities

10×10.2 g and 1×10.2 g foil laminate sachets of Panacur Equine Granules.

Further information

Panacur granules are odourless and tasteless and are readily consumed by animals.

Panacur has been extensively used for the treatment of worm infestations in exotic animal species. For further information on suggested dose rates, please contact the Veterinary Adviser of the company.

Studies have indicated that inhibited 3rd stage small strongyle larvae represent 50% of the total larval population in the horse.

Marketing authorisation number

Vm 01708/4424